Prospective Clinical and Molecular Evaluation of Potential Plasmodium ovale curtisi and wallikeri Relapses in a High-transmission Setting | Zendy

Mirjam Groger | Zendy; Luzia Veletzky | Zendy; Albert Lalremruata | Zendy; Chiara Cattaneo | Zendy; Johannes Mischlinger | Zendy; Rella Manego Zoleko | Zendy; Johanna Kim | Zendy; Anna Klicpera | Zendy; Elias Laurin Meyer | Zendy; Daniel Blessborn | Zendy; Markus Winterberg | Zendy; Ayôla Akim Adégnika | Zendy; Selidji Todagbé Agnandji | Zendy; Peter G. Kremsner | Zendy; Benjamin Mordmüller | Zendy; Ghyslain MomboNgoma | Zendy; HansPeter Fuehrer | Zendy; Michael Ramharter | Zendy

Open Access

Prospective Clinical and Molecular Evaluation of Potential Plasmodium ovale curtisi and wallikeri Relapses in a High-transmission Setting

Author(s) -

Mirjam Groger,

Luzia Veletzky,

Albert Lalremruata,

Chiara Cattaneo,

Johannes Mischlinger,

Rella Manego Zoleko,

Johanna Kim,

Anna Klicpera,

Elias Laurin Meyer,

Daniel Blessborn,

Markus Winterberg,

Ayôla Akim Adégnika,

Selidji Todagbé Agnandji,

Peter G. Kremsner,

Benjamin Mordmüller,

Ghyslain MomboNgoma,

HansPeter Fuehrer,

Michael Ramharter

Publication year - 2019

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciz131

Subject(s) - plasmodium ovale , parasitemia , medicine , genotyping , patent foramen ovale , prospective cohort study , foramen ovale (heart) , gastroenterology , cardiology , malaria , immunology , biology , plasmodium vivax , plasmodium falciparum , genotype , gene , genetics , migraine

Plasmodium ovale curtisi and wallikeri are perceived as relapsing malarial parasites. Contrary to Plasmodium vivax, direct evidence for this hypothesis is scarce. The aim of this prospective study was to characterize the reappearance patterns of ovale parasites.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research